Search research articles
Contact Us
Filters
Showing results (191-200 of 214) with videos related to
Page
of 22
Sort By:
JAMA Network Open
|
April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Science Translational Medicine
|
April 29, 2026
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4<sup>+</sup> T cell responses
Jillian M Jespersen, Lia Avanesyan, Jean Publicover, et al.
The Journal of Infectious Diseases
|
February 17, 2026
Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses
Davey Smith, Isabelle R Weir, Sydney Ramirez, et al.
Open Forum Infectious Diseases
|
September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy
Rinki Deo, Manish C Choudhary, Owen T Glover, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 29, 2024
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis
Adarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, et al.
Annals of Internal Medicine
|
April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
Nature Communications
|
October 28, 2022
A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma
Tira J Tan, W X Gladys Ang, Who-Whong Wang, et al.
Nature Microbiology
|
October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 22, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab
Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 214) with videos related to
Sort By:
Page
of 22
JAMA Network Open
|
April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Science Translational Medicine
|
April 29, 2026
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4<sup>+</sup> T cell responses
Jillian M Jespersen, Lia Avanesyan, Jean Publicover, et al.
The Journal of Infectious Diseases
|
February 17, 2026
Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses
Davey Smith, Isabelle R Weir, Sydney Ramirez, et al.
Open Forum Infectious Diseases
|
September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy
Rinki Deo, Manish C Choudhary, Owen T Glover, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 29, 2024
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis
Adarsh Bhimraj, Yngve Falck-Ytter, Arthur Y Kim, et al.
Annals of Internal Medicine
|
April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
Nature Communications
|
October 28, 2022
A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma
Tira J Tan, W X Gladys Ang, Who-Whong Wang, et al.
Nature Microbiology
|
October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 22, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab
Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Page
of 22